Warhound Launches With Massive Defense Funding

A new startup has emerged from stealth mode to address a critical gap in the nation's military canine supply chain.

Warhound, a company backed by $200 million in fresh capital, aims to engineer dogs specifically for dangerous tasks such as bomb detection and specialized searches. The funding round, which values the venture at $1.2 billion, includes investors like Sequoia, 8VC, Corner Ventures, and In-Q-Tel. The latter is a venture firm supported by the CIA and other U.S. intelligence agencies. The initiative was conceived by Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Lamm first met Luckey at a conference roughly a year ago, where Luckey expressed a desire to improve the lot of working dogs. This conversation led Lamm to research breeding practices, revealing that many dogs fail training due to inherited issues like poor eyesight, hip dysplasia, or cancer risks.

The U.S. military currently relies heavily on imports, with more than 80% of its working dogs coming from Europe. Of those imported animals, less than half are deemed fit for service. Warhound seeks to reverse this trend by using gene editing to create a new type of dog. The team has collected cell lines from top-performing breeds, specifically the Belgian Malinois and German Shepherd, and stored them in a biobank. Their goal is to add genes that enhance speed, agility, and olfactory sensors while removing those that lead to health problems. Viagen, another Colossal-owned entity, will handle the cloning process. Lamm noted that the first batch of dogs is about to be cloned and incubated, with births expected in early 2027. The company hopes these animals will begin service within two years.

Anduril will provide the technological layer, supplying hardware and software to assist both the dogs and their handlers. This includes protection vests and goggles equipped with data sensors. These devices will send real-time information back to handlers, improving situational awareness. Lamm described this as enhancing safety and performance on top of the dog, rather than inside it. He believes that healthier and better-protected dogs will perform more effectively in the line of duty. Luckey serves as a partner in the venture but holds no equity. Colossal owns equity and supports the business by licensing its technology. While Colossal is known for de-extinction projects like the dodo and mammoth, it is now applying its AI and gene cloning expertise to military applications.

The company has not yet determined its pricing model but expects to sell to first responders, the Department of Defense, and police forces. Lamm stated that the team has briefed various government groups on the business. Regarding civilian safety, he explained that each dog will undergo standard military training and be managed by its purchasing agency. To ensure ethical standards, Warhound is working under the guidance of the American Humane Society. The Society is helping to certify the training program for the new dogs. The company also hopes that when these dogs retire, they will enter the Society's Military Working Dog Reunification Program, which provides homes for retired military canines.

In a statement, the American Humane Society expressed its support for the collaboration. The organization said it applauds Warhound and Colossal for inviting a national humane organization grounded in science and ethics to the table. It added that it looks forward to working with them to ensure the animals are treated humanely. The partnership signals a significant shift in how the U.S. might approach the breeding and equipping of its four-legged service members.